What is the current Endovascular Repair (EVAR) market size?

The Endovascular Repair (EVAR) market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the EVAR market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by advancements in technology.

What are the key drivers of the Endovascular Repair market?

Increasing incidence of aortic aneurysms and growing demand for minimally invasive procedures drive the market.

What challenges does the EVAR market face?

High costs of procedures and risks of complications are major challenges for the Endovascular Repair market.

Which regions lead the Endovascular Repair market?

North America and Europe are the leading regions in the Endovascular Repair market due to high adoption rates.

Who are the top companies in the EVAR market?

Medtronic, Boston Scientific, and Cook Medical are among the top companies in the Endovascular Repair market.

What future opportunities exist for the Endovascular Repair market?

Emerging markets and advancements in technology present future opportunities for the Endovascular Repair market growth.

How does technology impact the EVAR market?

Advances in stent grafts and imaging technologies improve outcomes and drive the future outlook of the Endovascular Repair market.

What is the current regulatory landscape for the Endovascular Repair market?

Regulatory bodies such as the FDA and CE mark ensure safety and efficacy of EVAR devices, shaping the market landscape.

How Big Is the Endovascular Repair (EVAR) Market? Size, Share & Forecast 2033

Endovascular Repair (EVAR) by Application (Abdominal aortic aneurysm, Thoracic Aortic Dissection), by Types (Pararenal Area, Subrenal Area, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Endovascular Repair (EVAR) Market Size | CAGR 7.2 Forecast 2033

How Big Is the Endovascular Repair (EVAR) Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Endovascular Repair (EVAR) Market Overview

The Endovascular Repair (EVAR) market refers to the minimally invasive procedure used to treat abdominal aortic aneurysms (AAAs). As a critical aspect of vascular surgery, the Endovascular Repair (EVAR) market size is projected to experience significant growth, driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases. The growth outlook for the EVAR market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033. This industry expansion is expected to be shaped by key forces such as technological shifts, regulatory approvals, and changing consumer behavior, ultimately influencing the market size and growth prospects.

Loading chart…

The current Endovascular Repair (EVAR) market size is approximately $2.5 billion, with the largest region being North America, driven by the high prevalence of cardiovascular diseases and well-established healthcare infrastructure. The fastest-growing region is expected to be the Asia-Pacific, fueled by increasing healthcare expenditure, growing awareness of minimally invasive procedures, and rising demand for advanced medical technologies. Key forces shaping the industry include technology shifts, such as the development of advanced stent grafts, regulations, such as FDA approvals, and consumer behavior, such as the increasing preference for minimally invasive procedures. These factors are expected to drive the growth outlook and market forecast of the EVAR market, ultimately influencing the industry expansion and market size.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	4.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Gore; Cook Medical Inc.; Endologix; Cardinal Health; Boston Scientific; Abbott Laboratories; Volcano Corporation; Spectranetics International BV; AbbVie; Bolton Medical; Aptus Endosystems; Terumo (Vascutek); TriVascular; MicroPort Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Endovascular Repair (EVAR) market is experiencing significant growth, driven by various factors. The market dynamics are shaped by several key elements that influence the Endovascular Repair (EVAR) market size and growth forecast.

Growth Drivers2 items

Advances in technology, such as the development of new stent grafts and imaging systems, are driving the adoption of EVAR procedures, leading to an increase in the Endovascular Repair (EVAR) market size.

The rising prevalence of abdominal aortic aneurysms (AAAs) and increasing awareness about the benefits of minimally invasive procedures are contributing to the growth of the Endovascular Repair (EVAR) market.

Restraints2 items

High costs associated with EVAR procedures and devices are limiting access to these treatments, particularly in developing countries, and affecting the growth forecast of the Endovascular Repair (EVAR) market.

Stringent regulatory requirements and reimbursement issues are hindering the growth of the Endovascular Repair (EVAR) market, as companies face challenges in obtaining approval for new products and navigating complex payment systems.

Opportunities2 items

The increasing demand for minimally invasive procedures and the growing geriatric population are creating opportunities for companies to develop and market new EVAR devices, driving the Endovascular Repair (EVAR) market size.

Emerging markets, such as Asia-Pacific, offer significant growth opportunities for EVAR device manufacturers, driven by improving healthcare infrastructure and rising awareness about advanced treatments.

Challenges2 items

The Endovascular Repair (EVAR) market faces challenges related to device safety and efficacy, as companies must ensure that their products meet strict regulatory standards and demonstrate long-term benefits for patients.

Intense competition among EVAR device manufacturers is driving pricing pressure and forcing companies to invest in research and development to stay competitive and maintain market share in the Endovascular Repair (EVAR) market.

Market Segmentation

Loading chart…

The Endovascular Repair (EVAR) market can be segmented based on Application, which refers to the specific use cases of EVAR procedures. This segmentation category contributes to the overall market size by highlighting the different areas where EVAR is applied, such as abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA) repair. Understanding the Application segment is crucial for market players to identify opportunities and trends in the Endovascular Repair (EVAR) segmentation.

The Types of Endovascular Repair (EVAR) can be further sub-categorized into subtypes, including [object Object] and [object Object]. This segmentation category plays a significant role in determining the overall market size, as different types of EVAR procedures have varying levels of adoption and market demand. Analyzing the Types segment helps market researchers to identify the most prominent subtypes and their corresponding market shares, ultimately informing business strategies in the Endovascular Repair (EVAR) market.

Endovascular Repair (EVAR) Segmentation Breakdown7 items

Application

Abdominal aortic aneurysm

Thoracic Aortic Dissection

Types

Pararenal Area

Subrenal Area

Other

Regional Insights

Loading chart…

The Endovascular Repair (EVAR) market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share, driven by high adoption rates, favorable reimbursement policies, and significant investments in healthcare infrastructure. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing demand for minimally invasive procedures, improving healthcare infrastructure, and growing awareness about EVAR.

In Europe, established healthcare systems, high disease prevalence, and ongoing research initiatives are expected to drive the EVAR market growth. Latin America and Middle East & Africa are expected to experience steady growth, driven by expanding healthcare access, growing medical tourism, and increasing government investments in healthcare. The regional forecast indicates that these regions will play a crucial role in shaping the future of the EVAR market.

Competitive Landscape

The Endovascular Repair (EVAR) competitive landscape is moderately consolidated, with global players competing against local and regional companies. The market is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Endovascular Repair (EVAR) key players focus on these levers to gain a competitive edge in the market.

Companies in the EVAR market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their market position.

Medtronic: regional expansion

Gore: innovation pipeline

Cook Medical Inc.: premium pricing

Endologix: local manufacturing

Cardinal Health: OEM tie-ups

Boston Scientific: vertical integration

Key Endovascular Repair (EVAR) Companies15 items

Medtronic

Gore

Cook Medical Inc.

Endologix

Cardinal Health

Boston Scientific

Abbott Laboratories

Volcano Corporation

Spectranetics International BV

AbbVie

Bolton Medical

Aptus Endosystems

Terumo (Vascutek)

TriVascular

MicroPort Scientific

Market Ecosystem

The Endovascular Repair (EVAR) ecosystem encompasses a complex network of participants, spanning upstream technology providers, midstream integrators, and downstream channels, ultimately serving end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and delivery of EVAR products and services. The boundaries of this ecosystem extend from raw material suppliers to end users, with various intermediaries facilitating the flow of goods, services, and information.

Raw material suppliers — provide critical components

OEMs / manufacturers — design and produce EVAR devices

System integrators / EPCs — assemble and test EVAR systems

Distributors / channel partners — facilitate product delivery

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish and enforce industry standards

End users / buyers — purchase and utilize EVAR products

Within the Endovascular Repair (EVAR) ecosystem, value flows through the interactions and relationships among these participants. Control points, such as regulatory approvals and standards, influence the adoption of EVAR products. Dependency risks, including input constraints and approval timelines, can impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the dynamics of this ecosystem, which may differ by region due to varying regulatory environments and market conditions, highlighting the need for a thorough value chain analysis to understand the intricacies of the EVAR ecosystem.

Recent Industry Insights

The Endovascular Repair (EVAR) industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Abbott, have focused on advancing endovascular technologies. Mergers and acquisitions, like the acquisition of AorTech by Lombard Medical, have also been prominent. Furthermore, product launches, including the introduction of new stent grafts by Gore Medical, have expanded treatment options for patients. Regulatory changes, such as the updated guidelines for EVAR procedures by the FDA, have also impacted the industry. Additionally, there has been a notable shift in consumer trends, with an increasing preference for minimally invasive procedures.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Endovascular Repair (EVAR) market outlook. The market attractiveness is moderate, driven by increasing demand for minimally invasive procedures and advancements in technology. The competitive intensity is high, with key players investing heavily in research and development to improve product offerings. The long-term outlook is positive, with the market expected to grow steadily due to an aging population and rising incidence of aortic aneurysms.

The innovation landscape is rapidly evolving, with a focus on developing more efficient and effective devices. The demand–supply balance is expected to remain stable, with manufacturers working to meet the growing demand for EVAR devices. However, key risk factors such as regulatory changes and reimbursement issues may impact market growth. Overall, the EVAR market is poised for growth, driven by technological advancements and increasing adoption of minimally invasive procedures.

11 items

1. Executive Summary

2. Endovascular Repair (EVAR) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Endovascular Repair (EVAR) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Endovascular Repair (EVAR) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Abdominal aortic aneurysm

6.1.2. Thoracic Aortic Dissection

6.2. Global Endovascular Repair (EVAR) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Pararenal Area

6.2.2. Subrenal Area

6.2.3. Other

6.3. Global Endovascular Repair (EVAR) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Endovascular Repair (EVAR) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Endovascular Repair (EVAR) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Endovascular Repair (EVAR) Market Competition by Key Manufacturers

8.1. Global Endovascular Repair (EVAR) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Endovascular Repair (EVAR): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Gore

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cook Medical Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Endologix

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cardinal Health

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Boston Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Abbott Laboratories

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Volcano Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Spectranetics International BV

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. AbbVie

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bolton Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Aptus Endosystems

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Terumo (Vascutek)

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. TriVascular

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. MicroPort Scientific

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Endovascular Repair (EVAR) Market

Figure 4: Global Endovascular Repair (EVAR) Market: Drivers

Figure 5: Global Endovascular Repair (EVAR) Market: Challenges

Figure 6: Global Endovascular Repair (EVAR) Market: Trends

Figure 7: Global Endovascular Repair (EVAR) Market: Opportunity

Figure 8: Global Endovascular Repair (EVAR) Market: Restraint

Figure 9: Global Endovascular Repair (EVAR) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Endovascular Repair (EVAR) Market Value (USD Million) By Region

Figure 15: Global Endovascular Repair (EVAR) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Endovascular Repair (EVAR) Market Value (USD Million) By Region

Figure 23: Global Endovascular Repair (EVAR) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Endovascular Repair (EVAR) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Endovascular Repair (EVAR) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Endovascular Repair (EVAR) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Endovascular Repair (EVAR) Market Value (USD Million) By Region

Table 10: Global Endovascular Repair (EVAR) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Endovascular Repair (EVAR) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Endovascular Repair (EVAR) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Endovascular Repair (EVAR) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Gore Basic Information And Sales Area

Table 33: Gore. Products Portfolio

Table 34: Cook Medical Inc. Basic Information And Sales Area

Table 35: Cook Medical Inc.. Products Portfolio

Table 36: Endologix Basic Information And Sales Area

Table 37: Endologix. Products Portfolio

Table 38: Cardinal Health Basic Information And Sales Area

Table 39: Cardinal Health. Products Portfolio

Table 40: Boston Scientific Basic Information And Sales Area

Table 41: Boston Scientific. Products Portfolio

Table 42: Abbott Laboratories Basic Information And Sales Area

Table 43: Abbott Laboratories. Products Portfolio

Table 44: Volcano Corporation Basic Information And Sales Area

Table 45: Volcano Corporation. Products Portfolio

Table 46: Spectranetics International BV Basic Information And Sales Area

Table 47: Spectranetics International BV. Products Portfolio

Table 48: AbbVie Basic Information And Sales Area

Table 49: AbbVie. Products Portfolio

Table 50: Bolton Medical Basic Information And Sales Area

Table 51: Bolton Medical. Products Portfolio

Table 52: Aptus Endosystems Basic Information And Sales Area

Table 53: Aptus Endosystems. Products Portfolio

Table 54: Terumo (Vascutek) Basic Information And Sales Area

Table 55: Terumo (Vascutek). Products Portfolio

Table 56: TriVascular Basic Information And Sales Area

Table 57: TriVascular. Products Portfolio

Table 58: MicroPort Scientific Basic Information And Sales Area

Table 59: MicroPort Scientific. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Endovascular Repair (EVAR) Market Value (USD Million) By Region

Table 65: Global Endovascular Repair (EVAR) Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Endovascular Repair (EVAR) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	4.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Gore; Cook Medical Inc.; Endologix; Cardinal Health; Boston Scientific; Abbott Laboratories; Volcano Corporation; Spectranetics International BV; AbbVie; Bolton Medical; Aptus Endosystems; Terumo (Vascutek); TriVascular; MicroPort Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options